FULC Fulcrum Therapeutics, Inc. - Common Stock
$3,81
Kurs · Aug 18, 2026
Fundamentaldaten per Jul 30, 2026
52W-Spanne
$3–$16
8% of range
Analystenbewertung
HOLD
12 analysts
Kursziel
$3
P/E (TTM)
-3.2
ROE
-26.6%
Nettogewinnmarge
—
Über Fulcrum Therapeutics, Inc. - Common Stock Unternehmensübersicht von Wikipedia
FULC Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$3.81
Marktkapitalisierung
$254M
P/E (TTM)
-3.2
EPS (TTM)
$-1.18
Umsatz (TTM)
$0
Dividendenrendite
—
ROE
-26.6%
Verschuldungsgrad
—
52W-Spanne
$3 – $16
FULC Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$0
2020-12-31
→
2025-12-31
EPS
$-1.18
2020-12-31
→
2025-12-31
Freier Cashflow
$-60M
2019-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
FULC
Peer-Median
P/E (TTM)
-3.2
11.2
P/B (K/B)
0.7
2.2
Price / FCF (Kurs / FCF)
-4.2
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
FULC
Peer-Median
ROA
-23.9%
-16.0%
ROE
-26.6%
-29.0%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
FULC
Peer-Median
Current Ratio (Liquiditätsgrad)
27.4
5.1
Quick Ratio
15.1
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
FULC
Peer-Median
Revenue YoY (Umsatz YoY)
2752.0%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
61.0%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
FULC
Peer-Median
FULC Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
VERKAUF
12 Analysten
- Starker Kauf 0 0,0%
- Kauf 0 0,0%
- Halten 7 58,3%
- Verkauf 3 25,0%
- Starker Verkauf 2 16,7%
12-Monats-Kursziel
5 Analysten · 2026-08-16
Median
$3.00
Mittelwert
$3.40
Jetzt
$3.81
Tief
$3.00
Hoch
$4.00
Median-Ziel
$3.00
-21,3%
Mittelwert-Ziel
$3.40
-10,8%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.01%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.22 | $-0.22 | 0.00% |
| 31. März 2026 | $-0.25 | $-0.30 | 0.05% |
| 31. Dezember 2025 | $-0.31 | $-0.32 | 0.01% |
| 30. September 2025 | $-0.31 | $-0.30 | -0.01% |
| 30. Juni 2025 | $-0.28 | $-0.30 | 0.02% |
| 31. März 2025 | $-0.28 | $-0.30 | 0.02% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| FULC | $753M | -9.6 | 2752.0% | — | -26.6% | — |
| TTRX | $116M | -32.8 | — | — | -141.7% | — |
| NMRA | $312M | -1.2 | — | — | -165.2% | — |
| ANTX | $31M | -1.0 | — | — | -57.7% | — |
| SIGA | $438M | 19.1 | -31.8% | 24.6% | 11.4% | — |
| DERM | — | -16.4 | 10.2% | -18.5% | -44.7% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $80M | $3M | $6M | $19M | $9M | |
| R&D Expense | $56M | $63M | $72M | $77M | $70M | $59M | |
| SG&A Expense | $29M | $36M | $42M | $42M | $31M | $21M | |
| Operating Expenses | $85M | $102M | $113M | $119M | $100M | $80M | |
| Operating Income | $-85M | $-22M | $-111M | $-113M | $-81M | $-72M | |
| Income Tax | $0 | $0 | · | · | · | · | |
| Net Income | $-75M | $-10M | $-97M | $-110M | $-81M | $-71M | |
| EPS (Basic) | $-1.18 | $-0.16 | $-1.59 | $-2.44 | $-2.29 | $-2.79 | |
| EPS (Diluted) | $-1.18 | $-0.16 | $-1.59 | $-2.44 | $-2.29 | $-2.79 | |
| Shares (Basic) | 63,355 | 61,984 | 61,310 | 44,991 | 35,361 | 25,354 | |
| Shares (Diluted) | 63,355 | 61,984 | 61,310 | 44,991 | 35,361 | 25,354 | |
| EBITDA | $-85M | $-22M | $-111M | $-113M | · | $-72M |
Bilanz 21
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $198M | $58M | $26M | $35M | $35M | $57M | |
| Prepaid Expense | $5M | $7M | $5M | $4M | $4M | $4M | |
| Other Current Assets | · | · | · | · | $0 | $74.0K | |
| Current Assets | $357M | $250M | $242M | $208M | $226M | $120M | |
| PP&E (Net) | $3M | $4M | $5M | $7M | $7M | $8M | |
| PP&E (Gross) | $18M | $18M | $18M | $18M | $16M | $15M | |
| Accum. Depreciation | $16M | $14M | $13M | $11M | $8M | $6M | |
| Other Non-current Assets | $538.0K | $10.0K | $2M | $2M | $542.0K | $578.0K | |
| Total Assets | $366M | $261M | $258M | $227M | $235M | $130M | |
| Accounts Payable | $2M | $1M | $3M | $4M | $5M | $4M | |
| Current Liabilities | $13M | $11M | $14M | $17M | $19M | $27M | |
| Capital Leases | $4M | $6M | $9M | $11M | $0 | · | |
| Other Non-current Liabilities | $197.0K | $197.0K | $197.0K | $197.0K | $0 | · | |
| Total Liabilities | $17M | $18M | $23M | $28M | $23M | $34M | |
| Common Stock | $67.0K | $54.0K | $62.0K | $52.0K | $41.0K | $28.0K | |
| Retained Earnings | $-594M | $-519M | $-510M | $-412M | $-302M | $-222M | |
| Treasury Stock | · | · | · | $0 | $0 | · | |
| AOCI | $174.0K | $130.0K | $-136.0K | $-797.0K | $-397.0K | $-2.0K | |
| Stockholders' Equity | $349M | $243M | $235M | $199M | $212M | $95M | |
| Liabilities + Equity | $366M | $261M | $258M | $227M | $235M | $130M | |
| Shares Outstanding | 66,578,891 | 53,968,303 | 61,915,367 | 52,099,211 | 40,626,224 | 27,941,566 |
Cashflow 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $12M | $15M | $15M | $13M | $11M | $7M | |
| Restructuring | $400.0K | $2M | · | $400.0K | · | · | |
| Operating Cash Flow | $-60M | $-2M | $-91M | $-97M | $-78M | $-54M | |
| CapEx | $314.0K | $278.0K | $508.0K | $2M | $2M | $1M | |
| Investing Cash Flow | $31M | $32M | $-37M | $12M | $-130M | $-57M | |
| Stock Issued | $4M | $3M | $777.0K | $4M | $4M | $1M | |
| Net Stock Activity | $4M | $3M | $777.0K | $4M | · | $1M | |
| Financing Cash Flow | $169M | $3M | $118M | $84M | $187M | $71M | |
| Net Change in Cash | $139M | $33M | $-10M | $-314.0K | $-22M | $-40M | |
| Free Cash Flow | $-60M | $-2M | $-91M | $-99M | · | $-55M |
Rentabilität 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | -27.4% | -3945.2% | -1774.8% | · | -811.6% | |
| Net Margin | · | -12.2% | -3470.0% | -1732.4% | · | -802.7% | |
| EBITDA Margin | · | -27.4% | -3945.2% | -1774.8% | · | -811.6% | |
| ROA | -23.9% | -3.8% | -40.2% | -47.6% | · | -59.0% | |
| ROE | -26.6% | -3.9% | -39.7% | -52.3% | · | -70.8% |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 27.4 | 22.6 | 17.7 | 12.4 | · | 4.5 | |
| Quick Ratio | 15.1 | 5.3 | 1.9 | 2.1 | · | 2.1 |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.3 | 0.0 | 0.0 | · | 0.1 |
Wachstumsraten 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | · | 2752.0% | -55.8% | -66.9% | 117.2% | · | |
| Revenue CAGR 3Y | · | 61.0% | -31.8% | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $80M | $3M | $6M | $19M | $9M | |
| Net Income TTM | $-75M | $-10M | $-97M | $-110M | $-81M | $-71M | |
| Market Cap | $753M | $254M | $418M | $379M | · | $327M | |
| P/E | -9.6 | -29.4 | -4.2 | -3.0 | -7.7 | -4.2 | |
| P/S | · | 3.2 | 149.0 | 59.8 | · | 37.1 | |
| P/B | 2.2 | 1.0 | 1.8 | 1.9 | · | 3.4 | |
| P / Tangible Book | 2.2 | 1.0 | 1.8 | 1.9 | 3.4 | 3.4 | |
| P / Cash Flow | -12.5 | -114.4 | -4.6 | -3.9 | · | -6.1 | |
| P / FCF | -12.5 | -101.6 | -4.6 | -3.8 | · | -5.9 | |
| Earnings Yield | -10.4% | -3.4% | -23.6% | -33.5% | -13.0% | -23.8% |
Gewinn- und Verlustrechnung 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $0 | · | $0 | $0 | $80M | $0 | $871.0K | $759.0K | $880.0K | $295.0K | $685.0K | $1M | |
| R&D Expense | $12M | $14M | $15M | $14M | $13M | $13M | $12M | $15M | $17M | $20M | $19M | $18M | $18M | $17M | $19M | $15M | |
| SG&A Expense | $7M | $8M | $7M | $8M | $7M | $7M | $8M | $8M | $10M | $10M | $10M | $10M | $10M | $12M | $10M | $10M | |
| Operating Expenses | $29M | $22M | $23M | $22M | $20M | $20M | $19M | $25M | $28M | $30M | $29M | $28M | $28M | $28M | $29M | $26M | |
| Operating Income | $-29M | $-22M | $-23M | $-22M | $-20M | $-20M | $-19M | $-25M | $52M | $-30M | $-28M | $-27M | $-27M | $-28M | $-28M | $-24M | |
| Net Income | $-26M | $-19M | $-20M | $-20M | $-17M | $-18M | $-17M | $-22M | $55M | $-27M | $-25M | $-24M | $-24M | $-25M | $-26M | $-24M | |
| EPS (Basic) | $-0.34 | $-0.25 | $-0.31 | $-0.31 | $-0.28 | $-0.28 | $-0.27 | $-0.35 | $0.89 | $-0.43 | $-0.41 | $-0.39 | $-0.38 | $-0.41 | $-0.46 | $-0.51 | |
| EPS (Diluted) | $-0.34 | $-0.25 | $-0.31 | $-0.31 | $-0.28 | $-0.28 | $-0.25 | $-0.35 | $0.87 | $-0.43 | $-0.41 | $-0.39 | $-0.38 | $-0.41 | $-0.46 | $-0.51 | |
| Shares (Basic) | 76,264,000 | 76,215,000 | -187,556,645 | 62,597,000 | 62,544,000 | 62,479,000 | -186,536,016 | 62,409,000 | 62,205,000 | 61,984,000 | -123,615,412 | 61,823,000 | 61,794,000 | 59,722 | -82,756 | 46,213 | |
| Shares (Diluted) | 76,264,000 | 76,215,000 | -187,556,645 | 62,597,000 | 62,544,000 | 62,479,000 | -187,918,016 | 62,409,000 | 63,587,000 | 61,984,000 | -123,615,412 | 61,823,000 | 61,794,000 | 59,722 | -82,756 | 46,213 | |
| EBITDA | $-29M | $-22M | · | $-22M | $-20M | $-20M | · | $-25M | $52M | $-30M | · | $-27M | $-27M | $-28M | · | $-24M |
Bilanz 21
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $48M | $50M | $198M | $47M | $43M | $42M | $58M | $73M | $87M | $40M | $26M | $30M | $34M | $35M | $35M | $91M | |
| Prepaid Expense | $4M | $5M | $5M | $5M | $5M | $5M | $7M | $7M | $4M | $5M | $5M | $5M | $4M | $5M | $4M | $5M | |
| Other Current Assets | · | · | · | · | $69.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $323M | $339M | $357M | $206M | $219M | $233M | $250M | $267M | $280M | $218M | $242M | $262M | $283M | $303M | $208M | $228M | |
| PP&E (Net) | $0 | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $6M | $6M | $7M | $7M | $7M | |
| PP&E (Gross) | $1M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $17M | |
| Accum. Depreciation | $1M | $15M | $16M | $15M | $15M | $15M | $14M | $14M | $14M | $13M | $13M | $12M | $12M | $11M | $11M | $10M | |
| Other Non-current Assets | $9.0K | $546.0K | $538.0K | $9.0K | $12.0K | $10.0K | $10.0K | $76.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Total Assets | $324M | $347M | $366M | $215M | $229M | $243M | $261M | $279M | $294M | $233M | $258M | $279M | $300M | $321M | $227M | $248M | |
| Accounts Payable | $3M | $2M | $2M | $3M | $2M | $2M | $1M | $4M | $4M | $4M | $3M | $4M | $4M | $4M | $4M | $3M | |
| Current Liabilities | $10M | $10M | $13M | $12M | $9M | $8M | $11M | $15M | $13M | $11M | $14M | $14M | $15M | $14M | $17M | $15M | |
| Capital Leases | $3M | $3M | $4M | $5M | $5M | $6M | $6M | $7M | $8M | $8M | $9M | $9M | $10M | $10M | $11M | $11M | |
| Other Non-current Liabilities | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $197.0K | $447.0K | $320.0K | $197.0K | $197.0K | |
| Total Liabilities | $13M | $13M | $17M | $16M | $14M | $14M | $18M | $22M | $20M | $19M | $23M | $23M | $25M | $25M | $28M | $26M | |
| Common Stock | $76.0K | $67.0K | $67.0K | $54.0K | $54.0K | $54.0K | $54.0K | $54.0K | $62.0K | $62.0K | $62.0K | $62.0K | $62.0K | $62.0K | $52.0K | $52.0K | |
| Retained Earnings | $-639M | $-613M | $-594M | $-574M | $-554M | $-537M | $-519M | $-503M | $-481M | $-537M | $-510M | $-485M | $-461M | $-437M | $-412M | $-386M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | $0 | |
| AOCI | $-567.0K | $-513.0K | $174.0K | $241.0K | $82.0K | $70.0K | $130.0K | $379.0K | $-366.0K | $-434.0K | $-136.0K | $-886.0K | $-1M | $-651.0K | $-797.0K | $-921.0K | |
| Stockholders' Equity | $311M | $333M | $349M | $198M | $214M | $228M | $243M | $257M | $274M | $214M | $235M | $255M | $275M | $296M | $199M | $221M | |
| Liabilities + Equity | $324M | $347M | $366M | $215M | $229M | $243M | $261M | $279M | $294M | $233M | $258M | $279M | $300M | $321M | $227M | $248M | |
| Shares Outstanding | 76,285,157 | 66,608,096 | 66,578,891 | 54,108,438 | 54,091,588 | 53,979,306 | 53,968,303 | 53,938,661 | 62,250,631 | 62,141,011 | 61,915,367 | 52,099,211 | 52,099,211 | 61,758,994 | 52,099,211 | 52,049,913 |
Cashflow 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $4M | $4M | $4M | $3M | $4M | $3M | $4M | $3M | $3M | |
| Restructuring | $4M | · | $400.0K | $0 | $0 | $0 | $2M | $0 | · | · | · | · | · | · | · | $400.0K | |
| Operating Cash Flow | $-16M | $-19M | $-17M | $-14M | $-14M | $-15M | $-17M | $-19M | $59M | $-25M | $-23M | $-23M | $-21M | $-24M | $-20M | $-28M | |
| CapEx | $108.0K | $8.0K | $159.0K | $90.0K | $65.0K | $0 | $231.0K | $19.0K | $0 | $28.0K | $77.0K | $65.0K | $195.0K | $171.0K | $116.0K | $283.0K | |
| Investing Cash Flow | $14M | $-128M | $-1M | $19M | $14M | $-777.0K | $2M | $4M | $-13M | $38M | $18M | $19M | $20M | $-94M | $-36M | $-2M | |
| Stock Issued | $356.0K | $21.0K | $4M | $64.0K | $301.0K | $0 | $83.0K | $635.0K | $377.0K | $2M | $287.0K | $0 | $142.0K | $348.0K | $267.0K | $93.0K | |
| Net Stock Activity | · | $21.0K | · | · | · | $0 | · | · | · | $2M | · | · | · | $348.0K | · | · | |
| Financing Cash Flow | $356.0K | $-312.0K | $168M | $64.0K | $301.0K | $0 | $83.0K | $635.0K | $377.0K | $2M | $287.0K | $0 | $142.0K | $118M | $218.0K | $81M | |
| Net Change in Cash | $-2M | $-147M | $150M | $4M | $414.0K | $-16M | $-14M | $-14M | $47M | $14M | $-5M | $-4M | $-768.0K | $-364.0K | $-56M | $51M | |
| Free Cash Flow | · | $-19M | · | · | · | $-15M | · | · | · | $-25M | · | · | · | $-24M | · | · |
Rentabilität 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | 65.6% | · | · | -3615.3% | -3101.4% | -9471.2% | · | · | |
| Net Margin | · | · | · | · | · | · | · | · | 69.3% | · | · | -3164.3% | -2702.6% | -8399.7% | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | 65.6% | · | · | -3615.3% | -3101.4% | -9471.2% | · | · | |
| ROA | -9.5% | -6.4% | · | -7.9% | -6.6% | -7.4% | · | -7.8% | 22.6% | -10.1% | · | -9.1% | · | -9.2% | · | -9.4% | |
| ROE | -10.0% | -6.7% | · | -8.6% | -7.1% | -8.0% | · | -8.5% | 25.5% | -11.0% | · | -10.1% | · | -10.2% | · | -10.5% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 31.4 | 34.3 | · | 17.7 | 24.4 | 28.7 | · | 18.4 | 22.1 | 20.4 | · | 18.6 | · | 21.0 | · | 15.5 | |
| Quick Ratio | 4.7 | 5.1 | · | 4.0 | 4.7 | 5.2 | · | 5.0 | 6.8 | 3.7 | · | 2.1 | · | 2.4 | · | 6.2 |
Effizienz 1
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | · | · | 0.0 | 0.3 | 0.0 | · | 0.0 | · | 0.0 | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | $81M | · | $81M | $82M | $2M | · | $3M | $4M | $6M | · | $11M | |
| Net Income TTM | $-82M | $-73M | · | $-76M | $-1M | $-11M | · | $-17M | $-19M | $-99M | · | $-96M | $-106M | $-109M | · | $-104M | |
| Market Cap | $279M | $511M | · | $498M | $372M | $155M | · | $193M | $386M | $587M | · | $231M | · | $176M | · | $421M | |
| P/E | -3.1 | -6.8 | · | -7.5 | -172.0 | -15.2 | · | -11.9 | -18.8 | -5.9 | · | -2.6 | -1.5 | -1.2 | · | -3.2 | |
| P/S | · | · | · | · | · | 1.9 | · | 2.4 | 4.7 | 303.3 | · | 74.2 | · | 29.6 | · | 39.8 | |
| P/B | 0.9 | 1.5 | · | 2.5 | 1.7 | 0.7 | · | 0.7 | 1.4 | 2.7 | · | 0.9 | · | 0.6 | · | 1.9 | |
| P / Tangible Book | 0.9 | 1.5 | · | 2.5 | 1.7 | 0.7 | · | 0.7 | 1.4 | 2.7 | · | 0.9 | · | 0.6 | · | 1.9 | |
| P / Cash Flow | · | -27.2 | · | · | · | -10.2 | · | · | · | -23.2 | · | · | · | -7.3 | · | · | |
| P / FCF | · | -27.2 | · | · | · | -10.2 | · | · | · | -23.2 | · | · | · | -7.2 | · | · | |
| Earnings Yield | -32.2% | -14.6% | · | -13.3% | -0.58% | -6.6% | · | -8.4% | -5.3% | -17.1% | · | -38.1% | -64.5% | -83.9% | · | -31.5% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $0 | $80M | $3M | $6M | $19M |
| Betriebsgewinnmarge % | — | -27.4% | -3945.2% | -1774.8% | — |
| Nettoergebnis | $-75M | $-10M | $-97M | $-110M | $-81M |
| Verwässerte EPS | $-1.18 | $-0.16 | $-1.59 | $-2.44 | $-2.29 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 27.4 | 22.6 | 17.7 | 12.4 | — |
| Quick Ratio | 15.1 | 5.3 | 1.9 | 2.1 | — |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-60M | $-2M | $-91M | $-99M | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 169 Einreicher · $235.0M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 35 (+2 vs. Vorquartal) | 39 (+3 vs. Vorquartal) | 67 (-4 vs. Vorquartal) | 34 (-6 vs. Vorquartal) | +4.1M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| EcoR1 Capital, LLC | $23.972.510 | 6.549.866 | 10,20% | Aktien |
| TANG CAPITAL MANAGEMENT LLC | $23.868.368 | 6.521.412 | 10,15% | Aktien |
| Nantahala Capital Management, LLC | $20.038.646 | 5.475.040 | 8,53% | Aktien |
| MONTANOVA CAPITAL, LLC | $13.472.171 | 3.680.921 | 5,73% | Aktien |
| CITADEL ADVISORS LLC | $9.898.488 | 2.704.505 | 4,21% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $9.871.811 | 2.697.216 | 4,20% | Aktien |
| D. E. Shaw & Co., Inc. | $8.099.115 | 2.212.873 | 3,45% | Aktien |
| STATE STREET CORP | $7.455.512 | 2.037.025 | 3,17% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $7.320.000 | 2.000.000 | 3,11% | Aktien |
| GSK plc | $6.535.713 | 1.785.714 | 2,78% | Aktien |
| Qube Research & Technologies Ltd | $6.399.389 | 1.748.467 | 2,72% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $6.030.948 | 1.647.800 | 2,57% | Aktien |
| ADAR1 Capital Management, LLC | $5.728.006 | 1.565.029 | 2,44% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $5.438.039 | 1.485.803 | 2,31% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $4.516.515 | 1.233.727 | 1,92% | Aktien |
| JANE STREET GROUP, LLC | $4.371.332 | 1.194.353 | 1,86% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.322.262 | 1.180.946 | 1,84% | Aktien |
| Ikarian Capital, LLC | $3.839.929 | 1.049.161 | 1,63% | Aktien |
| BANK OF AMERICA CORP /DE/ | $3.764.884 | 1.028.657 | 1,60% | Aktien |
| Jump Financial, LLC | $3.678.300 | 1.005.000 | 1,56% | Aktien |
| VANGUARD GROUP INC | $3.580.169 | 316.549 | 1,52% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $3.296.957 | 900.808 | 1,40% | Aktien |
| GOLDMAN SACHS GROUP INC | $3.163.389 | 864.314 | 1,35% | Aktien |
| Assenagon Asset Management S.A. | $3.056.847 | 835.204 | 1,30% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $2.974.724 | 812.766 | 1,27% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.862.647 | 782.144 | 1,22% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $2.727.860 | 745.317 | 1,16% | Aktien |
| Balyasny Asset Management L.P. | $2.534.082 | 692.372 | 1,08% | Aktien |
| BlackRock, Inc. | $2.504.769 | 684.363 | 1,07% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $2.495.505 | 681.832 | 1,06% | Aktien |
| Point72 Asset Management, L.P. | $2.384.223 | 651.427 | 1,01% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.585.585 | 433.220 | 0,67% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.265.072 | 345.648 | 0,54% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.112.596 | 303.988 | 0,47% | Aktien |
| Peapod Lane Capital LLC | $1.046.021 | 285.798 | 0,45% | Aktien |
| Engineers Gate Manager LP | $885.720 | 242.000 | 0,38% | Aktien |
| EntryPoint Capital, LLC | $794.948 | 217.199 | 0,34% | Aktien |
| XTX Topco Ltd | $765.844 | 209.247 | 0,33% | Aktien |
| CITADEL ADVISORS LLC | $743.712 | 203.200 | 0,32% | Verkaufsoption |
| Quadrature Capital Ltd | $692.176 | 189.119 | 0,29% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $641.964 | 175.400 | 0,27% | Verkaufsoption |
| ALLIANCEBERNSTEIN L.P. | $639.448 | 83.370 | 0,27% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $570.477 | 155.868 | 0,24% | Aktien |
| Simplify Asset Management Inc. | $562.886 | 153.794 | 0,24% | Aktien |
| MARSHALL WACE, LLP | $500.860 | 136.847 | 0,21% | Aktien |
| Fiduciary Trust Co | $499.791 | 136.555 | 0,21% | Aktien |
| Squarepoint Ops LLC | $463.202 | 126.558 | 0,20% | Aktien |
| Verdad Advisers, LP | $458.320 | 125.224 | 0,19% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $435.679 | 119.038 | 0,19% | Aktien |
| HSBC HOLDINGS PLC | $426.477 | 109.353 | 0,18% | Aktien |
| Rangeley Capital, LLC | $420.497 | 114.890 | 0,18% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $374.784 | 102.400 | 0,16% | Aktien |
| ALGERT GLOBAL LLC | $370.978 | 101.360 | 0,16% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $349.607 | 95.521 | 0,15% | Aktien |
| TWO SIGMA ADVISERS, LP | $344.955 | 30.500 | 0,15% | Aktien |
| FMR LLC | $337.917 | 92.327 | 0,14% | Aktien |
| Headlands Technologies LLC | $328.386 | 89.723 | 0,14% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $314.032 | 85.801 | 0,13% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $313.223 | 85.580 | 0,13% | Aktien |
| Matisse Capital | $304.108 | 39.649 | 0,13% | Aktien |
| BARCLAYS PLC | $300.757 | 82.174 | 0,13% | Aktien |
| AXQ CAPITAL, LP | $298.228 | 81.483 | 0,13% | Aktien |
| Allostery Investments LP | $277.629 | 40.353 | 0,12% | Aktien |
| RHUMBLINE ADVISERS | $268.793 | 73.443 | 0,11% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $263.520 | 72.000 | 0,11% | Kaufoption |
| RBF Capital, LLC | $256.200 | 70.000 | 0,11% | Aktien |
| PRELUDE CAPITAL MANAGEMENT, LLC | $248.357 | 67.857 | 0,11% | Aktien |
| ALPS ADVISORS INC | $247.533 | 67.632 | 0,11% | Aktien |
| CITIGROUP INC | $217.217 | 59.349 | 0,09% | Aktien |
| FOX RUN MANAGEMENT, L.L.C. | $206.592 | 56.446 | 0,09% | Aktien |
| DEUTSCHE BANK AG\ | $191.714 | 52.381 | 0,08% | Aktien |
| Bank of New York Mellon Corp | $189.357 | 51.737 | 0,08% | Aktien |
| WELLS FARGO & COMPANY/MN | $181.887 | 49.696 | 0,08% | Aktien |
| STRS OHIO | $169.092 | 46.200 | 0,07% | Aktien |
| JANE STREET GROUP, LLC | $161.772 | 44.200 | 0,07% | Kaufoption |
| COMMONWEALTH EQUITY SERVICES, LLC | $146.400 | 40.000 | 0,06% | Aktien |
| Marquette Asset Management, LLC | $141.101 | 38.552 | 0,06% | Aktien |
| Nuveen Asset Management, LLC | $136.624 | 29.069 | 0,06% | Aktien |
| MetLife Investment Management, LLC | $124.729 | 34.079 | 0,05% | Aktien |
| CITADEL ADVISORS LLC | $124.440 | 34.000 | 0,05% | Kaufoption |
| PROFUND ADVISORS LLC | $119.001 | 32.514 | 0,05% | Aktien |
| SEI INVESTMENTS CO | $112.292 | 30.681 | 0,05% | Aktien |
| COUNTRY TRUST BANK | $109.950 | 30.041 | 0,05% | Aktien |
| LMR Partners LLP | $109.800 | 30.000 | 0,05% | Aktien |
| AlphaQuest LLC | $109.232 | 9.658 | 0,05% | Aktien |
| Aigen Investment Management, LP | $108.014 | 29.512 | 0,05% | Aktien |
| Scientech Research LLC | $104.617 | 28.584 | 0,04% | Aktien |
| Mariner, LLC | $102.861 | 28.104 | 0,04% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $100.010 | 27.325 | 0,04% | Aktien |
| CWM, LLC | $92.761 | 12.094 | 0,04% | Aktien |
| Nuveen, LLC | $92.426 | 25.253 | 0,04% | Aktien |
| MORGAN STANLEY | $92.045 | 25.149 | 0,04% | Aktien |
| Graham Capital Management, L.P. | $91.745 | 25.067 | 0,04% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $91.690 | 25.052 | 0,04% | Aktien |
| FRANKLIN RESOURCES INC | $90.845 | 24.821 | 0,04% | Aktien |
| Rafferty Asset Management, LLC | $89.809 | 24.538 | 0,04% | Aktien |
| JANE STREET GROUP, LLC | $87.840 | 24.000 | 0,04% | Verkaufsoption |
| MERCER GLOBAL ADVISORS INC /ADV | $78.214 | 21.370 | 0,03% | Aktien |
| Invesco Ltd. | $74.664 | 20.400 | 0,03% | Aktien |
| Castleview Partners, LLC | $69.906 | 19.100 | 0,03% | Aktien |
Unternehmensinsider 29 Insider · 13 Führungskräfte · 13 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Alex Sapir | President & Chief Executive Officer | 2. Februar 2026 A | 193.360 | 0 | 0 | $0 |
| Bryan Stuart | President & Chief Executive Officer | 19. Januar 2022 A | 0 | 0 | 0 | $0 |
| Esther Rajavelu | Chief Financial Officer | 9. Februar 2023 A | — | 0 | 0 | $0 |
| Judith Dunn | President, Research & Development | 19. Januar 2022 A | — | 0 | 0 | $0 |
| Melvin H. Hayes III | Chief Operating Officer | 26. April 2023 A | — | 0 | 0 | $0 |
| Greg Tourangeau | Principal Accounting Officer | 2. Februar 2026 A | 14.062 | 0 | 0 | $0 |
| Curtis Gale Oltmans | Chief Legal Officer | 2. Februar 2026 A | 10.252 | 0 | 1 | $-44.600 |
| Patrick Taylor Horn | Chief Medical Officer | 18. März 2024 A | — | 0 | 0 | $0 |
| Santiago Arroyo | Chief Medical Officer | 7. November 2022 A | — | 0 | 0 | $0 |
| Christopher Morabito | Chief Medical Officer | 19. Januar 2022 A | 1.100 | 0 | 0 | $0 |
| Christopher Moxham | Chief Scientific Officer | 10. August 2021 M | 0 | 0 | 0 | $0 |
| Owen B. Wallace | Chief Scientific Officer | 14. September 2020 M | 133.438 | 0 | 0 | $0 |
| Diego Cadavid | SVP Clinical Development | 1. Juli 2020 S | 65.714 | 0 | 0 | $0 |
| Sonja Banks | Direktor | 30. Juni 2026 A | — | 0 | 0 | $0 |
| Alan Ezekowitz | Direktor | 30. Juni 2026 A | 10.927 | 0 | 1 | $-65.700 |
| Colin Hill | Direktor | 30. Juni 2026 A | — | 0 | 0 | $0 |
| Kate Haviland | Direktor | 30. Juni 2026 A | — | 0 | 0 | $0 |
| Katina Dorton | Direktor | 30. Juni 2026 A | — | 0 | 0 | $0 |
| Rachel K. King | Direktor | 30. Juni 2026 A | — | 0 | 0 | $0 |
| Robert J Gould | Direktor | 30. Juni 2026 A | 469.864 | 0 | 4 | $-667.350 |
| James A Geraghty | Direktor | 30. Juni 2026 A | 90.714 | 0 | 0 | $0 |
| Joshua Lehrer-Graiwer | Direktor | 23. April 2026 A | — | 0 | 0 | $0 |
| James J. Collins | Direktor | 17. Juni 2024 A | — | 0 | 0 | $0 |
| Mark J Levin | Direktor | 10. November 2021 J | 3.962.202 | 0 | 0 | $0 |
| 6 Dimensions Capital, L.P. | 10%-Eigentümer | 22. Juli 2019 C | 559.821 | 0 | 0 | $0 |
| GSK plc | 10%-Eigentümer | 22. Juli 2019 C | 1.785.714 | 0 | 0 | $0 |
| Sanofi | 10%-Eigentümer | 22. Juli 2019 C | 558.035 | 0 | 0 | $0 |
| Alan A Musso | — | 2. Februar 2026 A | — | 0 | 0 | $0 |
| Peter G. Thomson | — | 19. Januar 2022 A | 2.300 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 35 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 0,59% | 10.748 NS | 30. April 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,41% | 21.230 NS | 30. April 2026 | N-PORT |
| IWC · iShares Trust | 0,05% | 203.387 SH | 8. August 2026 | Täglich |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 53.140 NS | 31. Mai 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,04% | 140.971 NS | 31. Mai 2026 | N-PORT |
| BIB · ProShares Trust | 0,02% | 2.464 NS | 31. Mai 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,02% | 3.588 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,02% | 411.384 SH | 8. August 2026 | Täglich |
| IWN · iShares Trust | 0,01% | 562.208 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 25.920 NS | 30. April 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 81.961 SH | 8. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,01% | 219.460 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 2.817 NS | 31. Mai 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,01% | 53.282 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 341.378 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 50.849 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 1.521.240 SH | 8. August 2026 | Täglich |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 228.499 NS | 31. Mai 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 2.203 NS | 31. Mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 2.227 NS | 31. Mai 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 1.960 NS | 30. April 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 2.209 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 56 NS | 31. Mai 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 3.000 NS | 30. April 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 10.997 NS | 31. Mai 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 7.834 NS | 30. April 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 30.377 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 110.458 SH | 8. August 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 23.143 SH | 8. August 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 10.048 NS | 30. April 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 15.348 NS | 30. April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 553.375 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.074.332 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.108 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,00% | 140.406 SH | 8. August 2026 | Täglich |